Olivier Sperandio

发表

Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.

Stéphanie Pérot, Olivier Sperandio, Maria A Miteva, 2010, Drug discovery today.

MTiOpenScreen: a web server for structure-based virtual screening

Pierre Tufféry, Olivier Sperandio, Céline M. Labbé, 2015, Nucleic Acids Res..

Target‐Based Virtual Screening to Address Protein–Protein Interfaces

Olivier Sperandio, Bruno O. Villoutreix, Maria A. Miteva, 2011 .

Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity

Pierre Tufféry, Olivier Sperandio, Michel Petitjean, 2009, BMC Bioinformatics.

The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections

Pierre Tufféry, Olivier Sperandio, David Lagorce, 2011, Bioinform..

An exploration of the 3D chemical space has highlighted a specific shape profile for the compounds intended to inhibit protein-protein interactions

Olivier Sperandio, Céline M. Labbé, Bruno O. Villoutreix, 2015, BMC Bioinformatics.

iPPI-DB: an online database of modulators of protein–protein interactions

Olivier Sperandio, Gert Vriend, Céline M. Labbé, 2015, Nucleic Acids Res..

In Silico ADME/Tox Predictions

Olivier Sperandio, Anne-Claude Camproux, David Lagorce, 2010 .

One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade.

Olivier Sperandio, Maria A Miteva, Bruno O Villoutreix, 2013, Drug discovery today.

Chemical Libraries for Virtual Screening

Olivier Sperandio, David Lagorce, Bruno O. Villoutreix, 2011 .

FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects

Olivier Sperandio, David Lagorce, Bruno O. Villoutreix, 2008, BMC Bioinformatics.

Structure-Based Virtual Screening

Olivier Sperandio, Bruno O. Villoutreix, Maria A. Miteva, 2011 .

Privileged Substructures to Modulate Protein-Protein Interactions

Olivier Sperandio, Marek Vavrusa, Mélaine A. Kuenemann, 2017, J. Chem. Inf. Model..

MED-SuMoLig: A New Ligand-Based Screening Tool for Efficient Scaffold Hopping

Olivier Sperandio, Bruno O. Villoutreix, Maria A. Miteva, 2007, J. Chem. Inf. Model..

In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.

Olivier Sperandio, Céline M. Labbé, David Lagorce, 2015, Progress in biophysics and molecular biology.

iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions.

Olivier Sperandio, Céline M. Labbé, Bruno O. Villoutreix, 2013, Drug discovery today.

wwLigCSRre: a 3D ligand-based server for hit identification and optimization

Pierre Tufféry, Olivier Sperandio, Michel Petitjean, 2009, Nucleic Acids Res..

FAF-Drugs3: a web server for compound property calculation and chemical library design

Olivier Sperandio, David Lagorce, Bruno O. Villoutreix, 2015, Nucleic Acids Res..

Fr-PPIChem: An academic compound library dedicated to protein-protein interactions.

Olivier Sperandio, Maria A Miteva, Bruno O Villoutreix, 2020, ACS chemical biology.

Free resources to assist structure-based virtual ligand screening experiments.

Olivier Sperandio, Maria A Miteva, Bruno O Villoutreix, 2007, Current protein & peptide science.

Rationalizing the chemical space of protein-protein interaction inhibitors.

Olivier Sperandio, Anne-Claude Camproux, Bruno O Villoutreix, 2010, Drug discovery today.

Which Three-Dimensional Characteristics Make Efficient Inhibitors of Protein-Protein Interactions?

Olivier Sperandio, Céline M. Labbé, Bruno O. Villoutreix, 2014, J. Chem. Inf. Model..

Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods

Olivier Sperandio, Anne-Claude Camproux, Bruno O. Villoutreix, 2010, PLoS Comput. Biol..

Phylogenetic analysis of Harmonin homology domains

Olivier Sperandio, Nicolas Wolff, Karen Druart, 2021, BMC Bioinform..

Computational analysis of protein-protein interfaces involving an alpha helix: insights for terphenyl–like molecules binding

Olivier Sperandio, Maria A Miteva, Adriana Isvoran, 2013, BMC Pharmacology and Toxicology.

Identification of novel small molecule inhibitors of activated protein C.

Olivier Sperandio, Bruno O Villoutreix, Roy Schrijver, 2014, Thrombosis research.

Stabilization of protein-protein interaction complexes through small molecules.

Olivier Sperandio, Maria A Miteva, Gert Vriend, 2016, Drug discovery today.

Combining Ligand- and Structure-Based Methods in Drug Design Projects

Olivier Sperandio, Bruno O. Villoutreix, Maria A. Miteva, 2008 .

Screening Outside the Catalytic Site: Inhibition of Macromolecular Inter-actions Through Structure-Based Virtual Ligand Screening Experiments

Olivier Sperandio, Maria A Miteva, Bruno O Villoutreix, 2008, The open biochemistry journal.

Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors

Olivier Sperandio, Céline M. Labbé, Mélaine A. Kuenemann, 2016, Scientific Reports.

Editorial: [Hot Topics: Toward the Design of Drugs on Protein-Protein Interactions]

Olivier Sperandio, O. Sperandio, 2012 .

Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches.

Olivier Sperandio, Bruno O Villoutreix, Nicolas Blondiaux, 2014, Journal of medicinal chemistry.

Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737

Olivier Sperandio, Bruno O Villoutreix, Benoit Deprez, 2014, Journal of biomolecular screening.

MED-3DMC: a new tool to generate 3D conformation ensembles of small molecules with a Monte Carlo sampling of the conformational space.

Olivier Sperandio, Maria A Miteva, Bruno O Villoutreix, 2009, European journal of medicinal chemistry.

Receptor-based computational screening of compound databases: the main docking-scoring engines.

Olivier Sperandio, Maria A Miteva, Bruno O Villoutreix, 2006, Current protein & peptide science.

How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis

Olivier Sperandio, Bruno O. Villoutreix, Maria A. Miteva, 2010, European Biophysics Journal.

Design of protein–membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V

Olivier Sperandio, Maria A Miteva, Bruno O Villoutreix, 2007, Proceedings of the National Academy of Sciences.

In silico studies of blood coagulation proteins: from mosaic proteases to nonenzymatic cofactor inhibitors.

Olivier Sperandio, Bruno O Villoutreix, B. Villoutreix, 2010, Current opinion in structural biology.

Editorial: Toward the design of drugs on protein-protein interactions.

Olivier Sperandio, 2012, Current pharmaceutical design.

Sampling of conformational ensemble for virtual screening using molecular dynamics simulations and normal mode analysis.

Olivier Sperandio, Maria A Miteva, Gautier Moroy, 2015, Future medicinal chemistry.

Rational design of small molecules targeting the C2 domain of coagulation factor VIII.

Olivier Sperandio, Bruno O Villoutreix, Mahesh Kulharia, 2014, Blood.

Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology

Jean-Luc Poyet, Olivier Sperandio, Maria A Miteva, 2014, Molecular informatics.